Diabetes Metab J.  2016 Apr;40(2):173-174. 10.4093/dmj.2016.40.2.173.

Response: The Association of Serum Cystatin C with Glycosylated Hemoglobin in Korean Adults (Diabetes Metab J 2016;40:62-9)

• Kang YH

• KMID: 2162091
• DOI: http://doi.org/10.4093/dmj.2016.40.2.173

Abstract

No abstract available.

MeSH Terms

Adult*
Cystatin C*
Hemoglobin A, Glycosylated*
Humans
Cystatin C

Reference

1. Sim EH, Lee HW, Choi HJ, Jeong DW, Son SM, Kang YH. The association of serum cystatin C with glycosylated hemoglobin in Korean adults. Diabetes Metab J. 2016; 40:62–69.

2. Ferguson MA, Waikar SS. Established and emerging markers of kidney function. Clin Chem. 2012; 58:680–689.

3. Servais A, Giral P, Bernard M, Bruckert E, Deray G, Isnard Bagnis C. Is serum cystatin-C a reliable marker for metabolic syndrome? Am J Med. 2008; 121:426–432.

4. Shankar A, Teppala S. Relationship between body mass index and high cystatin levels among US adults. J Clin Hypertens (Greenwich). 2011; 13:925–930.

5. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005; 352:2049–2060.

6. Sabanayagam C, Wong TY, Xiao J, Shankar A. Serum cystatin C and prediabetes in non-obese US adults. Eur J Epidemiol. 2013; 28:311–316.

7. Hare MJ, Shaw JE, Zimmet PZ. Current controversies in the use of haemoglobin A1c. J Intern Med. 2012; 271:227–236.

8. Raghav A, Ahmad J. Glycated serum albumin: a potential disease marker and an intermediate index of diabetes control. Diabetes Metab Syndr. 2014; 8:245–251.